Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

Last updated: January 13, 2025
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lymphoma

Treatment

N/A

Clinical Study ID

NCT06781437
RETRO-LYMPH
  • Ages > 18
  • All Genders

Study Summary

observational, non-interventional, retrospective, single-center study focusing on patients with lymphoma / lymphoproliferative syndrome between January 1980 and September 2021

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age greater than or equal to 18 years of enrollment

  • Diagnosis of lymphoma or lymphoproliferative syndrome between January 1980 andSeptember 2021

  • Signature of the informed consent form where applicable

Exclusion

Exclusion Criteria:

  • none

Study Design

Total Participants: 5500
Study Start date:
February 01, 2022
Estimated Completion Date:
December 31, 2027

Study Description

observational, non-interventional, retrospective, single-center study focusing on patients with lymphoma / lymphoproliferative syndrome between January 1980 and September 2021.

Study objectives are to enrich the data on the prognostic role of clinical and epidemiological factors associated with clinical and epidemiological data of patients;

  • to identify the factors that affect the evolution of the disease, such as lifestyle and occupational factors, as well as the type of treatment;

  • to provide a platform for future research projects;

  • Description of the various therapies that have occurred over time, duration of treatment, causes of interruption of treatment, responses;

  • Description of the adverse events / safety of the various therapies for lymphoma and lymphoproliferative syndromes;

  • Patient survival. Descriptive analyses will be conducted by tabulating frequency distributions and percentages and mean and median values, standard deviations, quartiles and extreme values for continuous variables. Progression-free survival, disease-free survival and overall survival will be examined using Kaplan-Meier point estimates

Connect with a study center

  • IRCCS Azienda Ospedaliero - Universitaria di Bologna

    Bologna, 40138
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.